[rank_math_breadcrumb]
Bio Tech, Pharmaceuticals, and Medical Devices
Karnataka is the biotech capital of India and a leading contributor to the success of Pharma, Biotech and medical devices in the country. Over 10% of India’s Pharma revenues and 60% of India’s Biotech revenues are from Karnataka. The state is home to 221 formulation units, 74 bulk drug units, 35 Clinical Research Organizations (CROs) and 12 Adverse Drug Reaction (ADR) Reporting Centers and contributes 12% of India’s pharma exports. Karnataka is the 1st state to formulate a comprehensive Biotech policy.
40%
Karnataka exports of its pharma output
33%
of India’s Biotech exports comes from Karnataka’s
60%
of India’s Biotech companies are in Karnataka
7500+
Biotech graduates every year from Karnataka
Sector Incentives and Policy
Industrial Policy Incentives
| Particulars | Incentives |
|---|---|
| Investment promotion subsidy | Up to 2.25% of annual turnover for 6-10 years Up to 40-60% Value of Fixed Assets |
| Land Conversion Fee | 100% reimbursement |
| Stamp Duty | 100% reimbursement |
| Concessional Registration Charges | 0.1% |
| Effluent Treatment Plants | 50% subsidy up to Rs. 250 L |
| Anchor Industries1 | INR 7-10 Cr subsidy |
- Subsidies are applicable only for the first industry in sub-administrative zones; to encourage investments in taluks where there are no industries with investments above INR 100 Cr and direct employment of 75 persons
New initiatives & opportunities
North cluster
India’s first private Aerospace SEZ with ~250 Acres area situated in Belagavi for A&D manufacturing and assembly
Central cluster
Aerospace research and innovation Centre collocated with IISc at Chitradurga. Flying training school at Davangere
South cluster
Hi-tech Aerospace and Defence park with ~1000 Acre area situated in Devanahalli, Bangalore for access to vast A&D ecosystem in Bangalore
MRO
World class Maintenance, Repair and Operations (MRO) facility planned in Bangalore, Mysuru to leverage recently announced tax rationalization
Initiatives and Growth Drivers
Cluster Development
1000+ Acres Bulk drug manufacturing park coming up in Kadechur, Yadigri, Bio Pharma & Wellness Cluster planned in Shivamogga, Pharma SEZ park in Hassan and Medical Devices Park in Mysuru.
Biotechnology Incubation Centers
Two biotechnology incubation centers in Mysuru and Dharwad to promote research in food tech and agriculture
Research and Talent
35+ Clinical research organisations and prominent institutions like IISC & Institute of Agri-biotechnology in the state readily cater to the research and talent requirements of the industry
Infrastructure Facilities
With Bangalore Helix biotechnology park, Bangalore bio cluster and pharma parks in Yadgir and Raichur, the state offers world class infrastructure facilities to enterprises.
Dynamic Biotech Ecosystem
As the first state to formulate biotech policy, the government envisages presence of a vibrant and dynamic pharma and biotech ecosystem in the state
Sector Champions
Amardeep Singh Ahluwalia
Sr. Vice President- Corporate Affairs,
Jubilant Foodworks Limited
The Jubilant Bhartia Group, has a strong presence in diverse sectors like Pharmaceuticals, Life Science Ingredients and Drug Discovery Services, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. Jubilant Bhartia Group has three flagships Companies- Jubilant Life Sciences Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited, listed on Indian Stock Exchanges. Currently the group has a global workforce of around 39,000 employees.
Siddharth Mittal
Joint MD, CEO & Director
Biocon Industries
Biocon Limited, is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.
Sector Contact
Email: [email protected]
Phone: 9811356519
